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Staphylococcus aureus can undergo phenotypic switching between a normal colony
phenotype (NCP) and a small colony variant (SCV). The SCV phenotype confers
increased antibiotic resistance and the capacity to persist within human tissues and
cells, and because these cells can revert back to the NCP they cause chronic and/or
recurrent infections that are very difficult to treat. A complete picture of the genetic
events that can lead to phenotypic switching in S. aureus is currently lacking. We
describe the selection of an SCV with a previously unreported genetic alteration leading
to an ochre mutation of aroD. In addition to the known mechanisms of phenotypic
switching between the SCV and the NCP we describe a previously unreported
mechanism involving tRNA ochre suppressors arising. The ochre suppressor strains had
wild-type growth rates and restored antibiotic sensitivity, similar to the wild-type strain.
However, whilst they had increased virulence compared to the SCV parent strain, their
virulence was not restored to that of the NCP parental strain. These findings establish
that phenotypic switching between the NCP and SCV states can give rise to strains with
different pathogenic potential.
Keywords: Staphylococcus aureus, small colony variants, ochre mutation, phenotypic switching, aroD
INTRODUCTION
Staphylococcus aureus small colony variants (SCVs) are a naturally arising slow-growing
subpopulation of S. aureus. They are termed SCVs because their colonies are about 1/10 the size
of normal colonies on agar after 24 h of growth. S. aureus SCVs are frequently associated with
persistent and recurrent infections, such as osteomyelitis, implant infections and airway infections
in cystic fibrosis patients (von Eiff et al., 2006), or patients receiving long-term antibiotic treatment
(Proctor et al., 1995; von Eiff et al., 1997a, 2001). This is in part because SCVs can persist within
non-phagocytic host cells such as epithelial cells (Atalla et al., 2010), endothelial cells (von Eiff
et al., 1997b) and bone cells (Wright and Nair, 2010). This is because SCVs have reduced toxin
production and do not induce an immune response (Tan et al., 2014; Ou et al., 2016). In addition
genes responsible for adhesion and biofilm formation are generally upregulated in SCVs (Proctor
et al., 2006), enhancing the capacity of the bacterium to persist in implant infections, cystic fibrosis
patients, and osteomyelitis.
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Staphylococcus aureus SCVs isolated from patients are
often found to be auxotrophic for metabolites such as heme,
menadione, or thymidine (Proctor et al., 2006). The auxotrophic
nature of SCVs, generally, seems to relate to the antibiotic
treatment that the patient was receiving with aminoglycosides
giving rise to heme and menadione auxotrophs (Balwit et al.,
1994), while trimethoprim-sulfamethoxazole treatment gives rise
to thymidine auxotrophs (Kriegeskorte et al., 2015). A number of
studies have shown that SCVs can also be generated by exposure
to very low levels of triclosan (Bayston et al., 2007; Seaman et al.,
2007; Latimer et al., 2012). However, the auxotrophy of these
SCVs was not defined and the likelihood of them arising in situ in
clinical settings is questionable because of the levels of triclosan
in hand washes and other cleaning products (Seaman et al., 2007;
Latimer et al., 2012). Heme and menadione are required for the
synthesis of cytochromes and menaquinone, respectively. These
molecules are essential for respiration and thus SCVs defective
in the biosynthesis of either of these two molecules switch to
generating energy via fermentation resulting in reduced growth
and bacterial numbers, they have a decreased bacterial membrane
potential, and thus a decreased electrochemical gradient, which
is associated with increased resistance to antimicrobials (Sendi
and Proctor, 2009; Mike et al., 2013). Thymidine auxotrophs have
similar phenotypes to heme and menadione auxotrophs due to
decreased TCA cycle activity, which results in down-regulation
of the ETC (Proctor et al., 2014).
The SCV phenotype is usually unstable and phenotypic
switching back to the normal colony phenotype (NCP) occurs
(Massey et al., 2001; Kahl, 2014). This phenotypic switching
may explain why SCV infections recur after periods of apparent
remission (Kahl, 2014). Whilst numerous studies on S. aureus
SCVs have been published, there are only a few studies that
show the genetic basis for phenotypic switching back to the NCP
and the frequency of reversion (Vestergaard et al., 2016). It was
reported that phenotypic switching from SCV to NCP restored
antibiotic sensitivity and haemolytic activity to that of the wild-
type (Lannergård et al., 2008; Dean et al., 2014). Given the nature
of the reversions one might predict that other phenotypes, such
as the capacity to form biofilms and virulence, would be restored
to normal wild-type levels, though this was not examined.
In this study, we isolated a spontaneous menadione
auxotrophic SCV to determine the genetic basis of SCV
reversion to NCP and the consequences of this phenotypic
switching on antibiotic resistance, biofilm formation, and
virulence. We determined that this SCV had a point mutation in
the aroD gene, which has not been previously reported. The gene
encodes 3-dehydroquinate dehydratase, an enzyme participating
in the shikimate pathway that catalyzes the conversion of
3-dehydroquinate to 3-dehydroshikimate, the third step in
the shikimate pathway leading to the synthesis of chorismate.
Chorismate is a precursor for the synthesis of a range of aromatic
compounds, including aromatic amino acids and menaquinone.
As expected, this SCV is auxotrophic for all aromatic amino
acids and menaquinone. Two classes of revertant arose upon
phenotypic switching to the NCP, those in which the aroD
gene mutation was reversed and those that had a compensatory
mutation in one of two tyr-tRNA genes.
MATERIALS AND METHODS
Strains, Plasmids, and Oligonucleotides
The bacterial strains and plasmids used in this study are
summarized in Tables 1, 2, respectively. The oligonucleotides
used are listed in Supplementary Table S1. E. coli was grown
under aerobic conditions in Luria-Bertani (LB) broth or LB agar
(supplemented with 10 µg/ml ampicillin to maintain plasmids
when required) at 37◦C. S. aureus was grown under aerobic
conditions in tryptic soy broth (TSB) or tryptic soy agar (TSA)
at 37◦C. Appropriate antibiotics (erythromycin at 5 µg/ml or
chloramphenicol at 10 µg/ml) were supplemented if the strains
carried antibiotic markers. The S. aureus SCV, SCV445, was
grown in the presence of 50 µg/ml kanamycin to select against
phenotypic switching to the NCP.
Growth Experiments in TSB
For the characterization of S. aureus growth dynamics in
TSB, a starter culture was prepared by inoculating a single
colony of S. aureus into 5 ml TSB containing appropriate
antibiotics and grown for 16 h. The optical density at 600 nm
TABLE 1 | Bacterial strains used in this study.
Strains Properties Reference
E. coli DH5α Cloning host Invitrogen
S. aureus RN4220 Restriction deficient strain derived from S. aureus 8325-4 Kreiswirth et al., 1983
S. aureus LS-1 S. aureus septic arthritis isolate from mice Bremell et al., 1990
S. aureus 8325-4 Wild-type laboratory strain Novick, 1967
S. aureus 8325-4 menD S. aureus 8325-4 with ermC gene inserted in menD Bates et al., 2003
S. aureus SCV445 Spontaneous SCV derived from S. aureus LS-1 with mutation in aroD This study
S. aureus LS-1 aroD S. aureus LS-1 with nucleotides 448–717 bp deleted in aroD This study
S. aureus LS-1 menD S. aureus LS-1 with erm gene inserted in menD This study
S. aureus LS-1 1hemB S. aureus LS-1 derivative 1hemB Wright and Nair, 2012
PZ160-163 Revertant of SCV445 with a wild-type aroD gene This study
PZ164 A revertant of SCV445 carrying mutation in tyr-tRNA. This study
PZ165 A revertant of SCV445 carrying mutation in tyr-tRNA This study
Frontiers in Microbiology | www.frontiersin.org 2 May 2017 | Volume 8 | Article 1001
fmicb-08-01001 May 30, 2017 Time: 16:59 # 3
Zhang et al. Mechanisms of aroD SCV Reversion
TABLE 2 | Plasmids used in this study.
Plasmid Characteristics Reference
pKOR1 Inducible promoter Pxyl/tetO controlling antisense secY, lambda recombination sites, attp,
flanking a ccdB gene. Ampr (G− selection), Cmr (G+ selection)
Bae and Schneewind, 2006
pSK236 Shuttle vector containing pUC19 cloned into the HindIII site of pC194. Ampr (G− selection),
Cmr (G+ selection)
Gaskill and Khan, 1988
pHCMC05 Shuttle vector containing inducible promoter lacI-Pspac Nguyen et al., 2005
pPZ138-7 pKOR1 derivative with ccdB replaced by the upstream and downstream sequences of
S. aureus aroD gene
This study
pPZ137-3 pSK236 derivative with Pspac-aroD cloned in multiple cloning site This study
pAAO1 pUC57 derivative containing a synthetic aroD gene (aroDtyr) with a 450A > T change compared
to the wild-type. The gene was flanked by BamHI and XbaI.
Genscript (this study)
pSK236::aroDtyr pSK236 derivative with Pspac-aroDtyr cloned in multiple cloning site This study
G+, Gram-positive; G−, Gram-negative; Ampr, ampicillin-resistant; Cmr, chloramphenicol-resistant.
(OD600 nm) of the starter culture was measured using a Pharmacia
Biotech Ultrospec 2000 UV/Visible Spectrophotometer (GE
Healthcare Life Sciences, Buckinghamshire, United Kingdom),
then diluted in TSB supplemented with appropriate antibiotics
and/or indicated substance to a calculated OD600 nm of 0.05.
This was then incubated at 37◦C with shaking at 200 rpm.
Growth was monitored by measuring the OD600 nm at 1-h
intervals, or by determining colony-forming units (CFU/ml)
every 3 h by spreading serial dilutions of the culture onto TSA
and incubating aerobically at 37◦C for 24–48 h before colonies
were counted.
Growth Experiments in Chemically
Defined Media (CDM)
The CDM used to characterize S. aureus growth dynamics was
adapted from a described recipe (Pattee and Neveln, 1975),
the constituents are listed in Supplementary Table S2. A starter
culture was prepared by inoculating a single colony of S. aureus
into 5 ml TSB containing appropriate antibiotics, which was
then grown for 16 h. The cells were collected by centrifugation
at 2500 × g for 5 min, washed once with phosphate buffered
saline (PBS, pH = 7.4), and re-suspended in 5 ml of the CDM
used for growth experiments. The OD600 nm of the suspension
was measured, followed by diluting into CDM to a calculated
OD600 nm of 0.05. The remaining steps were as described for the
growth experiments in TSB.
DNA Sequencing
Genomic DNA from S. aureus strains was prepared from
overnight cultures using QIAamp DNA Mini Kit (Qiagen).
Overnight cultures of SCV445 were grown in TSB with
50 µg/ml of kanamycin, an aliquot of which was plated out
on TSA to establish that none of the cell population had
undergone phenotypic switching from SCV to NCP, before
the remaining culture was used to obtain DNA. All DNA
fragments for sequencing were amplified using Vent DNA
polymerase (New England Biolabs). The primers used for
PCR amplification and sequencing are listed in Supplementary
Table S3. Sanger sequencing was performed by Genewiz UK
Limited.
Construction of aroD and menD Mutants
Deletion of the aroD gene in S. aureus LS-1 was performed
according to the method of Bae and Schneewind (2006) and as
previously described (Wright and Nair, 2012). A deletion from
nucleotide 448 bp to 717 bp was constructed by amplifying
regions flanking the gene using primer pairs P194/P195 and
P196/P197.
A S. aureus LS-1 menD mutant was constructed by
homologous recombination. A 3.1 kb fragment containing
menD disrupted by an ermC insertion was amplified from
S. aureus 8325-4 menD::ermC (Bates et al., 2003) using primers
P125 and P126. The amplified fragment was treated with T4
polynucleotide kinase and ligated to pKOR1 which had been
digested with EcoRI and EcoRV and treated with Klenow
fragment. Subsequent steps were as described previously (Wright
and Nair, 2012). The insertion of ermC into menD in the
chromosome of LS-1 was confirmed by PCR amplification using
primers P125 and P128.
Complementation of the aroD Mutant
To complement the aroD mutant, the aroD gene from S. aureus
LS-1 was amplified using primers P192 and P193. The PCR
product was digested using BamHI and XbaI. The lacI-Pspac
region of plasmid pHCMC05 was excised (Nguyen et al., 2005)
using SacI and BamHI, and together with the aroD fragment
was ligated with SacI-XbaI digested pSK236 to give plasmid
pPZ137-3, which was introduced into the aroD mutant as
previously described (Wright and Nair, 2012). In addition a
synthetic aroD gene, with a base change at 448 of A to T, flanked
by BamHI and XbaI sites was synthesized by Genscript and
cloned as described above to complement the aroD mutant with
a mutated aroD gene (aroDtyr) coding for a K149Y substitution.
Characterization of SCV445
Auxotrophism
Disk diffusion assays were used to determine the auxotrophic
phenotype of SCV445 as previously described (Bauer et al., 1966).
Heme (Fluka), menadione (Sigma), and thymidine (Fluka) were
prepared at 1, 10, 100, and 1000 µg/ml, along with negative
controls, and 15 µL of each substance was inoculated on to a disk
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and placed in the center of a TSA plate onto which SCV445 had
been spread.
Susceptibility to Antimicrobial Agents
The minimum inhibitory concentration (MIC) of kanamycin
against S. aureus LS-1, SCV445 and the phenotypically switched
strains PZ164 and PZ165 were determined in TSB according
to a protocol described previously (Wiegand et al., 2008) and
following CLSI guidelines (M07-A10). Briefly, an overnight
culture was prepared by growing a single colony of S. aureus
in 5 ml TSB for 16 h. The culture was diluted in fresh TSB
to approximately 1 × 106 CFU/ml. Aliquots of 50 µl were
added to an equal volume of TSB containing antibiotics at
a range of concentrations 0, 1, 2, 4, 8, 16, 32, 64, 128, 256,
512, and 1024 µg/ml in polystyrene 96-well plates (Thermo
Scientific NUNC). The microtiter plate was incubated at 37◦C
with shaking at 200 rpm. The MIC was defined as the lowest
concentration of antibiotic that resulted in no detectable bacterial
growth.
Measurement of the Frequency of
Phenotypic Switching
The frequency of SCV445 phenotypic switching to the NCP was
measured in fluctuation tests as originally described by Luria
and Delbrück (1943). A colony of SCV445 on TSA containing
50 µg/ml kanamycin was inoculated into 10 ml TSB containing
50 µg/ml kanamycin, followed by incubation at 37◦C with
agitation at 200 rpm overnight. The 100 µl aliquots 10-fold serial
dilutions of the culture were spread on TSA and incubated at
37◦C. TSA plates were visually scanned for fast-growing NCP
colonies after 24 and 48 h of incubation. The mutation rate
was calculated according to the formula µ = −(1/N) ln P0,
where µ is the mutation rate per cell per generation, N is the
total number of colonies counted, and P0 is the proportion of
SCV phenotype colonies. Visually identified NCP colonies were
streaked on TSA and compared to the wild-type LS-1 to confirm
the normal-growth phenotype.
Biofilm Formation
Staphylococcus aureus was grown overnight in TSB, pelleted by
centrifugation and resuspended to an OD600 nm of 0.02 in BHI
containing 1% glucose. Bacterial suspensions were inoculated
into 96 well microtiter plates (200 µl per well) and incubated
statically for 24 h at 37oC. Plates were washed three times
with PBS and stained with 0.1% crystal violet for 5 min. The
plates were rinsed with water to remove excess dye and then
dried. The dye was solubilized by adding 200 µl of 33% glacial
acetic acid to each well and incubated for 10 min with shaking.
Biomass was measured by reading the absorbance at 590 nm.
For determination of P-values, paired Student’s t-tests were
performed.
Galleria mellonella Virulence Assay
The Galleria mellonella virulence assay was performed essentially
as described previously (Peleg et al., 2009) with slight
modification. Galleria mellonella (obtained from Cornish Crispa
Co, United Kingdom) in the larval stage and weighing 0.2–
0.3 g were used to study the virulence of S. aureus. Ten
randomly picked individuals were used in each experiment for
each strain, and all the strains were tested in three independent
experiments. S. aureus strains were cultured in TSB with
appropriate antibiotics at 37◦C for 16 h. The cultures were
centrifuged at 2500 × g for 5 min and the supernatant was
removed. Cells were washed once with PBS, then resuspended
in PBS to 1.0 × 109 CFU/ml. The 10 µl of the cell suspension
or PBS was injected into the hemocoel of the larvae via the last
left pro-leg. Once infected, larvae were incubated at 37◦C for
5 days, and the survival rate scored every 24 h. Kaplan–Meier
survival analysis was performed on the data and the significance
of the difference between the percentage survivals of G.mellonella
infected with different strains was determined using the Log
Rank test. A p-value of less than 0.05 was considered statistically
significant.
RESULTS
Isolation of a S. aureus SCV and
Characterization of the Auxotrophic
Phenotype
A S. aureus SCV, SCV445, was selected by growth of S. aureus
LS-1 on TSB agar plates containing 50 µg/ml kanamycin.
This strain exhibited typical SCV phenotypes: pinpoint colonies
about 1/10 of the size of the wild-type, which were mannitol
fermentation negative and had low coagulase activity and low
haemolytic activity (data not shown). SCV445 also had greatly
increased resistance to kanamycin compared to the wild-type.
The MIC of kanamycin against the wild-type LS-1 strain was
16 µg/ml, while it increased to 256 µg/ml for SCV445. The
auxotrophism of SCV445 was determined using the disk diffusion
method, and it was found that menadione restored growth but
hemin or thymidine did not (data not shown).
Identification of the Genetic Mutation in
SCV445
To identify the genetic basis of the SCV phenotype of SCV445,
genes involved in menadione biosynthesis were amplified and
sequenced. These included previously identified menadione
biosynthetic genes menA, menB, menC, menD, menE, menF
(Nowicka and Kruk, 2010), a gerC locus (also named hepT-
menG-hepS), and genes with locus tags SAOUHSC_01348
and SAOUHSC_02556. The gerC locus has been reported
to be involved in menadione biosynthesis in Bacillus subtilis
(Leatherbarrow et al., 1998), and SAOUHSC_01348 and
SAOUHSC_02556 are homologs of a thioesterase-encoding
gene that participates in menadione biosynthesis in the
cyanobacterium Synechocystis sp. PCC6803 (Widhalm et al.,
2009). Unexpectedly, no mutations were found in any of these
genes when SCV445 was compared to the wild-type strain.
To investigate whether a mutation occurred in genes coding
for enzymes involved in a pathway upstream of menadione
biosynthesis, we investigated the shikimate pathway which is
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shown in Figure 1. The products of the aro genes are responsible
for the synthesis of chorismate, which is a branching point
for several metabolic pathways, including aromatic amino acid
biosynthesis, folate biosynthesis and menaquinone biosynthesis.
Therefore a mutation in any of the aro genes would cause
a defect in the other metabolic pathways downstream of
chorismate in addition to menadione auxotrophy. Therefore to
test the hypothesis that there was a defect in the shikimate
pathway, we measured the growth of SCV445 and the wild-type
LS-1 in defined medium with or without the aromatic amino
acids phenylalanine, tyrosine, and tryptophan. Surprisingly, both
SCV445 and LS-1 were unable to grow in the absence of aromatic
amino acids (Figure 2). To examine this further, we tested the
growth of both strains in defined medium in the absence of each
of the individual aromatic amino acids. The wild-type strain LS-
1 was unable to grow in the absence of tyrosine, while SCV445
failed to grow in the absence of any single aromatic amino acid
(Figure 3). This finding suggested the presence of a mutation in
a gene involved in tyrosine synthesis in the wild-type strain LS-1,
while the mutation in SCV445 conferring the SCV phenotype was
likely to be in one of the aro genes.
To locate the mutation in SCV445, the seven aro genes were
amplified from both LS-1 and SCV445 and sequenced. Sequence
alignment between S. aureus LS-1 and SCV445 showed that the
aroD gene in SCV445 had a substitution of 448A > T, resulting
in the 149th codon changing from AAA (lysine), to a stop
codon TAA. Given that the product of aroD, 3-dehydroquinate
dehydratase, is essential for the synthesis of chorismate, this
mutation was likely to be the cause of both the menadione and
the aromatic amino acid auxotrophy in SCV445. To confirm this,
we constructed an aroD mutant of LS-1 by deleting the sequence
beyond nucleotide 447 in the aroD gene and adding a TAA stop
codon to the truncated gene. The LS-1 aroD mutant exhibited
the same phenotypes as SCV445, menadione and aromatic amino
acid auxotrophy (data not shown) and had a reduced growth
compared to LS-1 (Figure 4). Expression of aroD in trans from
the plasmid pPZ137-3 in the aroD deletion strain of LS-1 restored
its prototrophic phenotype (data not shown) and growth rate to
the same level of LS-1 (Figure 4).
Disruption of aroD in S. aureus Results in
a Greater Capacity to Form Biofilm
As mentioned, apart from SCVs that arose as a result of triclosan
treatment (Latimer et al., 2012) the SCV phenotype in S. aureus
has generally been reported to be associated with increased
biofilm formation (Mitchell et al., 2010a,b). SCV445, an aroD and
amenD deletion mutant of strain LS-1 all had a greater capacity to
form biofilms than the LS-1 wild-type strain (Figure 5). Given the
SCVs are slow growing compared to the wild-type, the increased
capacity to form biofilms is remarkable, if the SCVs also grow
slowly in the biofilm. Unexpectedly, a hemB deletion mutant of
LS-1 had a reduced capacity to form biofilms compared to the
parent strain (Figure 5).
FIGURE 1 | Schematic representation of the shikimate pathway and several downstream biosynthetic pathways in S. aureus. The pathway is modified from KEGG
(Kyoto Encyclopedia of Genes and Genomes) pathways: phenylalanine, tyrosine, and tryptophan biosynthesis, http://www.genome.jp/kegg/pathway/map/map
00400.html.
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FIGURE 2 | Neither the SCV SCV445 nor the parent strain LS-1 can grow in chemically defined medium lacking aromatic amino acids. Growth of S. aureus LS-1
and SCV445 in chemically defined medium (CDM). CDM without aromatic amino acids (CDM – AAAs). Data are presented as the mean of three independent
experiments with error bars showing the standard deviations.
FIGURE 3 | The SCV SCV445 requires all three aromatic amino acids to grow in CDM. Growth of S. aureus LS-1 and SCV445 in chemically defined medium (CDM)
with or without aromatic amino acid(s). LS-1+ or SCV445+:S. aureus LS-1 or SCV445 with the three aromatic amino acids (AAAS). LS-1- or SCV445-:S. aureus
LS-1 or SCV445 without the three AAAs. LS-1 phe- or SCV445 phe-: bacteria grown in CDM without phenylalanine but with the other two AAAs. LS-1 tyr- or
SCV445 tyr-: bacteria grown in CDM without tyrosine but with the other two AAAs. LS-1 try- or SCV445 try-: bacteria grown in CDM without tryptophan but with the
other two AAAs. Data are presented as the mean of three independent experiments with error bars showing standard deviations.
Rate of Phenotypic Switching from SCV
to NCP
In three independent cultures plated out on TSA plates no
NCPs were visible after 24 h of incubation, while a total of six
large colonies were identified from the three cultures after 48 h
of incubation, suggesting phenotypic switching had occurred.
Streaking these six colonies on TSA confirmed that they were
NCPs that formed normal sized colonies after 24 h incubation.
In three independent experiments, the reversion rates were
determined to be 2.29 × 10−8, 2.83 × 10−8, and 1.52 × 10−7
per cell per generation giving a mean rate of 6.79× 10−8 per cell
per generation.
Genetic Basis for Phenotypic Switching
from SCV to NCP
The aroD gene was amplified from the six clones that had
switched back to NCPs and their sequences analyzed. Four of
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FIGURE 4 | Disruption of aroD in S. aureus results in a growth defect similar to that of SCV445 and this can be complemented in trans by a plasmid borne copy of
aroD. Viable counts of strains LS-1, LS-1 1aroD pSK236 (plasmid without an insert), LS-1 1aroD pPZ137-3 (pSK236::aroD) and SCV445 growing in TSB at
different time points. Data are presented as the means of three independent experiments with error bars showing the standard deviations.
FIGURE 5 | Disruption of aroD in S. aureus results in a greater capacity to
form biofilm. Biofilm formation on plastic plates in BHI containing 1% glucose.
Bacteria were added to microtiter wells at an OD600 nm of 0.02 and incubated
for 24 h statically at 37◦C. The bars represent the mean with error bars
showing the standard deviation. ∗∗∗P < 0.001.
the NCPs had the same aroD sequence as the original wild-
type, whereas the other two NCPs (PZ164 and PZ165) retained
the same mutation as SCV445. Furthermore there were no
other mutations in the gene or the intergenic region of aroD in
these clones. We reasoned that the only way these clones could
have the NCP phenotype was if a functional 3-dehydroquinate
dehydratase was still produced despite the presence of the aroD
mutation. One possible mechanism that could account for this
was that these clones may possess a tRNA gene with a mutated
anticodon that recognizes the stop codon UAA and therefore
allows read through translation of their aroD mRNA. There
are seven tRNA molecules with a complementary anticodon
that, with a single base change, could recognize an UAA stop
codon. These are tRNA-tyrosine (UAU), tRNA-tyrosine (UAC),
tRNA-leucine (UUA), tRNA-serine (UCA), tRNA-lysine (AAA),
tRNA-glutamine (CAA), and tRNA-glutamic acid (GAA). The
gene encoding each of these was amplified and sequenced.
A mutation was found in the tyr-tRNA gene of both NCPs that
had switched from the SCV phenotype and retained the aroD
mutation. As shown in Figure 6, the tyr-tRNA mutation causes
an anticodon change from AUG to AUU, which would therefore
recognize the stop codon UAA. While both NCPs had the same
mutation they were in different copies of the two tyr-tRNA genes
FIGURE 6 | Graphic illustration of the mechanism that a tyr-tRNA mutation
restores a functional AroD in PZ164 and PZ165 (Murgola, 1990).
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in S. aureus (corresponding to locus tags SAOUHSC_T00057
and SAOUHSC_T00058 in the genome sequence of strain
NCTC8325).
The Two NCP tyr-tRNA Mutants Have
Equivalent Planktonic Growth
Characteristics to the Wild-type, Have
the Same Capacity to Form Biofilms and
Have Restored Aminoglycoside
Sensitivity
The difference between the 3-dehydroquinate dehydratase
produced by the wild-type strain and the two tyr-tRNA mutants
was a K149Y substitution. Given the NCP of the two-tRNA
mutants, this amino acid substitution must be tolerated, giving an
enzyme that retains activity. However, the suppressor tyr-tRNAs
in PZ164 and PZ165 should partially repress the translation
termination of genes with TAA stop codons, which could affect
global gene expression and therefore impact on other phenotypes.
To test this possibility we initially examined the susceptibility to
kanamycin, planktonic growth characteristics and the capacity
of PZ164 and PZ165 to form biofilms. PZ164 and PZ165 had
identical sensitivity to kanamycin as the wild-type LS-1 and the
four NCP revertants PZ160 – PZ163 (16 µg/ml), similar growth
rates to LS-1 (Figure 7) and similar capacities to form biofilms
as the wild-type and revertants PZ160 – PZ163 (Figure 8). To
confirm that the 3-dehydroquinate dehydratase with a K149Y
substitution, which would be produced in the ochre suppressor
strains, accounted for the NCP we complemented the LS-1
aroD mutant with a mutated gene encoding this change using
plasmid pSK236::aroDtyr. This trans complementation restored
the NCP (data not shown) and resulted in similar growth to LS-1
(Figure 9).
The SCV Strains and the Two NCP
tyr-tRNA Mutants Are Attenuated in a
Galleria mellonella Infection Model
The virulence potential of the wild-type LS-1, the SCV, SCV445,
the aroD mutants and the two tyr-tRNA mutants (PZ164 and
PZ165) was evaluated using a G. mellonella infection model.
Figure 10 shows a Kaplan–Meier plot for survival of infected
G. mellonella over time. Compared to the parental strain LS-
1, SCV445 and the defined aroD mutant showed significantly
reduced virulence (P < 0.001) and there was no significant
difference between SCV445 and LS-1 aroD mutant (P = 0.171).
Complementation with a functional aroD gene using plasmid
pPZ137-3 restored the virulence of the defined mutant to the
same levels as the wild-type. The Kaplan–Meier plot shown in
Figure 11 demonstrates that compared to the parental strain LS-1
both tyr-tRNA mutants have significantly attenuated virulence
(P < 0.001).
DISCUSSION
Studies on S. aureus SCVs have focused on hemin or menadione
auxotrophs, mainly using stable defined hemB and menD
mutants (von Eiff et al., 1997b, 2006; Bates et al., 2003; Sifri
et al., 2006). S. aureus SCVs are frequently isolated from
patients, but the genetic basis of SCV phenotypes is not
often characterized (Kahl et al., 2003; Yagci et al., 2013).
Nevertheless, those SCVs that have been characterized have
demonstrated that mutations in hemB or menD are not the
only mutations that can give rise to the SCV phenotype.
For example mutations in menB (Lannergård et al., 2008),
menC, menE, menF (Dean et al., 2014), hemH (Schaaff et al.,
2003), and relA, a gene that encodes guanosine polyphosphate
pyrophosphohydrolase/synthetase (ppGpp synthetase) (Gao
et al., 2010), give rise to a SCV phenotype. Herein, we report
an S. aureus SCV with a previously undescribed genotype, an
ochre mutation in the aroD gene. Although this mutation would
result in a defect in the biosynthesis of a number of metabolites,
including aromatic amino acids, folate and menaquinone,
supplementation of growth medium with menadione alone
was sufficient to reverse the SCV phenotype. The finding
that a previously undescribed mutation results in menadione
auxotrophy, and the SCV phenotype, suggests that there may
be an under appreciation of the range of mutations that lead
to this phenotype. Indeed, although the novel aroD SCV we
isolated has similar growth characteristics and capacity to form
biofilms as the menD SCV, and a reduced virulence potential
as reported for the menD SCV (Sifri et al., 2006), it is probable
that SCVs resulting from different genetic changes will have
different pathogenic phenotypes. In support of this hypothesis
is our finding that, while the menadione auxotrophic SCVs
(due to mutation of either aroD or menD) had an increased
capacity to form biofilms, the hemB SCV was less able to form
biofilms than the wild-type. Therefore, knowledge of the full
range of genetic changes that can lead to the SCV phenotype
is necessary if we are to fully understand how these organisms
persist during infection and to develop effective treatments
against SCVs.
One reason why natural SCVs have not been well studied is
that they are thought to be very unstable and quickly undergo
phenotypic switching back to the NCP (Becker et al., 2006).
However, a relatively low reversion rate of 6.79 × 10−8 per
cell per generation was determined for the aroD SCV, SCV445,
described in this study. In addition, a similar reversion rate of
1.8 × 10−8 per cell per generation was reported for a clinically
isolated S. aureus menB mutant (Lannergård et al., 2008) and
more recently for in vitro generated gentamicin resistant SCVs
(Vestergaard et al., 2016). These mutation frequencies are within
the range of those reported for spontaneous rifampicin resistant
S. aureus mutants (between 3.5 × 10−7 and 1.10 × 10−8 per
cell per generation) thus these data suggest that spontaneously
formed SCVs are as stable as the NCP, and that phenotypic
switching occurs as frequently as other spontaneous mutations.
This is also consistent with the findings reported by Edwards
(2012) that the formation of SCVs from NCP cells is a natural
process during replication rather than a consequence of selective
pressure, and that SCV-NCP switching occurs spontaneously
during bacterial replication in the absence of selective pressure
(Edwards, 2012). Given that by our reasoning SCVs are not
particularly unstable, why is it frequently reported that they are?
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FIGURE 7 | The NCP tyr-tRNA mutants grow at the same rate as the wild-type strain LS-1. Viable counts of strains LS-1, PZ164, and PZ165 growing in TSB at
different time points. Data are presented as the means of three independent experiments with error bars showing the standard deviations.
FIGURE 8 | Phenotypic switching from the SCV to the NCP restores the
wild-type biofilm phenotype regardless of the genetic mechanism. Biofilm
formation on plastic plates in BHI containing 1% glucose. Bacteria were
added to microtiter wells at an OD600 nm of 0.02 and incubated for 24 h
statically at 37◦C. The bars represent the mean with error bars showing the
standard deviations. ∗∗∗P < 0.001.
This is probably due to the fact that upon phenotypic switching
of a cell from the SCV to the NCP, the NCP cell replicates much
more rapidly than the SCV cells, quickly giving rise to a very high
proportion of NCP cells within a culture. This may explain the
higher SCV reversion rates of 1.76 × 10−6 and 1.21 × 10−6 per
cell per generation observed by Dean et al. (2014), where SCVs
were serially passaged in broth without selection for 3–10 days.
It has been assumed that phenotypic switching between
the SCV phenotype and the NCP was due to reversion of
FIGURE 9 | Disruption of aroD in S. aureus results in a growth defect similar
to that of SCV445 and this can be complemented in trans by a plasmid borne
copy of a synthetic aroD gene coding for a K149Y substitution. Growth curves
(OD600 nm) of strains LS-1, LS-1 aroD pSK236 (plasmid without an insert) and
LS-1 aroD containing pSK236::aroDtyr growing in TSB at different time points.
Data are presented as the means of three independent experiments with error
bars showing the standard deviations.
the mutation that initially led to the SCV phenotype. Indeed
until fairly recently studies on the genetic basis for phenotypic
switching of S. aureus SCVs to NCP have been consistent
with this assumption (Lannergård et al., 2008; Dean et al.,
2014). More recently Vestergaard et al. (2016) have found new
pathways that compensate for the growth fitness of gentamicin
resistant SCVs, however, they did not investigate what effect these
mutations had on other phenotypes such as biofilm formation
and virulence (Vestergaard et al., 2016). We have found that
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FIGURE 10 | The SCV strains are attenuated for virulence in Galleria mellonella. Percentage survival of G. mellonella infected with S. aureus strains and monitored
over 5 days. G. mellonella were infected with either the wild-type strain LS-1, or the SCV (SCV445), or an aroD mutant of LS-1 (LS-11aroD) or an aroD mutant of
LS-1 complemented with aroD in trans (LS-11aroD::aroD). Data are presented as the percentages of 30 worms, which were assayed in groups of 10 on three
different days.
FIGURE 11 | The NCP tyr-tRNA mutants are attenuated for virulence in Galleria mellonella. Percentage survival of G. mellonella infected with S. aureus strains and
monitored over 5 days. G. mellonella were infected with either the wild-type LS-1, or the NCP tyr-tRNA mutants PZ164 and PZ165. Data are presented as the
percentages of 30 worms, which were assayed in groups of 10 on three different days.
phenotypic reversion can occur via the generation of tRNA-Tyr
ochre suppressors, which has not been described previously for
SCVs. These findings demonstrate that there are a number of
possible genetic events that can lead to phenotypic switching
to the NCP apart from the widely reported reversion of the
original mutation. Such NCPs may have different phenotypes
compared to the wild-type strain and the SCV from which they
were derived. In support of this hypothesis is our finding that
while the two NCP tyr-tRNA mutants arising from SCV445 had
many of the phenotypes of the wild-type strain LS-1, they had
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reduced virulence in theG.mellonella infection model. Given that
the reduced virulence of SCVs is associated with their ability to
persist in the host, it is tempting to speculate that the tyr-tRNA
NCPs might have more potential to persist in the host than the
wild-type strain and therefore cause distinct clinical problems
from either the wild-type NCP and the SCV.
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